Dr. James Rahal, Infectious Disease Specialist, also available as Expert Resource
FLUSHING, N.Y., Oct. 30 /PRNewswire-USNewswire/ -- The following is being issued by New York Hospital Queens:
WHAT: A special briefing on methicillin-resistant Staphylococcus
aureus(MRSA) is scheduled for media and community leaders.
James Rahal, M.D., and a team of infectious disease
specialists from New York Hospital Queens will address the
basis of concern about this infection. They will discuss the
risks, and address the fear caused by recent cases of
community-acquired MRSA infection in the New York area.
During the briefing, the date and location of a community
education program is expected to be announced.
WHEN: Thursday, November 1, 2007 at 10 a.m.
WHERE: New York Hospital Queens 56-45 Main Street, Flushing NY
Lang Auditorium (please leave 15 minutes for access from
FYI: Methicillin-resistant Staphylococcus aureus (MRSA) is a type
of Staph that is resistant to commonly used antibiotics. MRSA
infections occur most frequently among persons in hospitals
and healthcare facilities (such as nursing homes and dialysis
centers) who have weakened immune systems.
MRSA infections that are acquired by healthy persons in the
community who have not been recently (within the past year)
hospitalized or had a medical procedure are known as
Community Acquired-MRSA infections (CA-MRSA). These CA-MRSA
infections are usually manifested as skin infections, such as
pimples, boils, or abscesses; and rarely, pneumonia. For
background on healthcare and community-acquired infections,
as well as infection control guidance, including in school
settings, go to http://www.cdc.gov/ncidod.
NYHQ conducts ongoing surveillance for infectious diseases,
as well as targeted research. An original article based upon
a multi-year investigation into the impact on MRSA is being
published in the November issue of the journal Infection
Control and Hospital Epidemiology.
CONTACT: Cynthia Bacon
|SOURCE New York Hospital Queens|
Copyright©2007 PR Newswire.
All rights reserved